Vulvovaginal candidiasis (VVC) is extremely common, affecting 70-75% of women at least once in their lives. Recurrent VVC, defined as four or more proven episodes in 12 months, affects 5-8% of these women and can cause a significant amount of discomfort and distress. Some women are referred to tertiary centres but, with good evidencebased treatment, many women could be managed in primary care.
